Urology
Volume 72, Issue 1 , Pages 10-14, July 2008

Bladder Cancer in Native Americans and Alaskan Natives

  • Richard A. Watson

      Affiliations

    • Department of Surgery, Division of Urology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Hackensack, New Jersey
    • Department of Urology, Hackensack University Medical Center, Hackensack, New Jersey
    • Corresponding Author InformationReprint requests: Richard A. Watson, M.D., Department of Surgery, Division of Urology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, and Division of Ambulatory Urology, Department of Urology, Hackensack University Medical Center, Sanzari Building, Suite 403, 360 Essex Street, Hackensack, NJ 07601.
    • ,
  • Monika Sidor

      Affiliations

    • Department of Surgery, Division of Urology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Hackensack, New Jersey

Received 22 August 2007; accepted 21 December 2007. published online 02 April 2008.

Objectives

The prevalence of bladder cancer among Native Americans/Alaskan Natives (NAs/ANs) is generally considered to be low. However, the relative morbidity and mortality seem high. We have undertaken this survey of the published data to explore and document this observation.

Methods

An extensive survey of the published data was undertaken. The Surveillance, Epidemiology and End Results data in particular were assessed.

Results

The incidence of bladder cancer among the NA/AN peoples is inexplicably low. This low incidence is more remarkable, given the widespread use of tobacco products and the disproportionately high incidence of kidney cancer in this same population. Despite this low incidence, NA/AN men and women seem to be at a relatively greater risk of dying of bladder cancer, once it has been diagnosed.

Conclusions

More and larger studies are needed to clarify and update the incidence, cell type, and clinical outcomes of bladder cancer among NA/AN men and women. Social, economic, and political barriers to treatment also need to be addressed. Effective steps need to be undertaken to ensure more timely diagnosis and treatment of this disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0090-4295(07)02683-0

doi:10.1016/j.urology.2007.12.087

Urology
Volume 72, Issue 1 , Pages 10-14, July 2008

Article Tools